SG49239A1 - Amylin and possibly insulin containing composition for the treatment of aneroxia and related states - Google Patents

Amylin and possibly insulin containing composition for the treatment of aneroxia and related states

Info

Publication number
SG49239A1
SG49239A1 SG1996008180A SG1996008180A SG49239A1 SG 49239 A1 SG49239 A1 SG 49239A1 SG 1996008180 A SG1996008180 A SG 1996008180A SG 1996008180 A SG1996008180 A SG 1996008180A SG 49239 A1 SG49239 A1 SG 49239A1
Authority
SG
Singapore
Prior art keywords
amylin
treatment
aneroxia
pct
containing composition
Prior art date
Application number
SG1996008180A
Other languages
English (en)
Inventor
Timothy J Rink
Andrew A Young
Original Assignee
Amylin Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amylin Pharmaceuticals Inc filed Critical Amylin Pharmaceuticals Inc
Publication of SG49239A1 publication Critical patent/SG49239A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG1996008180A 1991-05-24 1992-05-23 Amylin and possibly insulin containing composition for the treatment of aneroxia and related states SG49239A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70499591A 1991-05-24 1991-05-24
US86250092A 1992-04-03 1992-04-03

Publications (1)

Publication Number Publication Date
SG49239A1 true SG49239A1 (en) 1998-05-18

Family

ID=27107425

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996008180A SG49239A1 (en) 1991-05-24 1992-05-23 Amylin and possibly insulin containing composition for the treatment of aneroxia and related states

Country Status (11)

Country Link
US (1) US5656590A (da)
EP (1) EP0586589B1 (da)
JP (1) JPH06510754A (da)
AT (1) ATE157010T1 (da)
AU (1) AU669110B2 (da)
CA (1) CA2109794A1 (da)
DE (1) DE69221725T2 (da)
DK (1) DK0586589T3 (da)
ES (1) ES2108122T3 (da)
SG (1) SG49239A1 (da)
WO (1) WO1992020367A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU222249B1 (hu) * 1991-03-08 2003-05-28 Amylin Pharmaceuticals Inc. Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
RU2177331C2 (ru) * 1993-09-07 2001-12-27 Амилин Фармасьютикалз, Инк. Способы регулирования моторики желудочно-кишечного тракта
AUPM678294A0 (en) * 1994-07-13 1994-08-04 Gropep Pty Ltd Use of insulin-like growth factor in combination with insulin
US5783556A (en) * 1996-08-13 1998-07-21 Genentech, Inc. Formulated insulin-containing composition
US7910548B2 (en) 1997-06-06 2011-03-22 Amylin Pharmaceuticals, Inc. Methods for treating obesity
US6621131B2 (en) * 2001-11-01 2003-09-16 Intel Corporation Semiconductor transistor having a stressed channel
WO2004060387A1 (en) * 2002-12-27 2004-07-22 Diobex, Inc. Compositions and methods for the prevention and control of insulin-induced hypoglycemia
US7655618B2 (en) 2002-12-27 2010-02-02 Diobex, Inc. Compositions and methods for the prevention and control of insulin-induced hypoglycemia
WO2005021026A2 (en) * 2003-08-29 2005-03-10 Amylin Pharmaceuticals, Inc. Methods for treating or ameliorating ghrelin-associated diseases and disorders
EP2010208A1 (en) * 2006-03-31 2009-01-07 Amylin Pharmaceuticals, Inc. Amylin and amylin agonists for treating psychiatric diseases and disorders

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8514090D0 (en) * 1985-06-04 1985-07-10 Sandoz Ltd Organic compounds
JPS61194034A (ja) * 1985-02-25 1986-08-28 Teijin Ltd 経鼻投与用粉末状組成物
US5008241A (en) * 1985-03-12 1991-04-16 Novo Nordisk A/S Novel insulin peptides
DK119785D0 (da) * 1985-03-15 1985-03-15 Nordisk Gentofte Insulinpraeparat
GB8720115D0 (en) * 1987-08-26 1987-09-30 Cooper G J S Treatment of diabetes mellitus
GB8709871D0 (en) * 1987-04-27 1987-06-03 Turner R C Peptides
DE3717370A1 (de) * 1987-05-22 1988-12-01 Hoechst Ag Mischkristalle aus insulin und insulinderivaten, verfahren zur herstellung dieser mischkristalle, diese mischkristalle enthaltende pharmazeutische mittel und ihre verwendung zur behandlung von diabetes mellitus
US4992418A (en) * 1987-07-17 1991-02-12 Mount Sinai School Of Medicine Superactive human insulin analogue-[10-Aspartic Acid-B]Human Insulin
US4992417A (en) * 1987-07-17 1991-02-12 Mount Sinai School Of Medicine Superactive human insulin analogues
US5049547A (en) * 1988-02-11 1991-09-17 University Patents, Inc. Composition for stimulating integumental melanocytes
GB8915712D0 (en) * 1989-07-08 1989-08-31 Macintyre Iain Medical treatment
CA2020786A1 (en) * 1989-07-10 1991-01-11 Amylin Pharmaceuticals, Inc. Treatment of obesity and essential hypertension and related disorders
US5016643A (en) * 1990-05-02 1991-05-21 Board Of Regents, The University Of Texas System Vascular entoptoscope
US5234906A (en) * 1991-01-10 1993-08-10 Amylin Pharmaceuticals, Inc. Hyperglycemic compositions
CA2109604A1 (en) * 1991-05-24 1992-11-26 Timothy J. Rink Insulin and amylin containing composition for the treatment of insulin deficient mammals

Also Published As

Publication number Publication date
WO1992020367A1 (en) 1992-11-26
DK0586589T3 (da) 1997-09-22
EP0586589A1 (en) 1994-03-16
CA2109794A1 (en) 1992-11-26
AU669110B2 (en) 1996-05-30
JPH06510754A (ja) 1994-12-01
ATE157010T1 (de) 1997-09-15
DE69221725D1 (de) 1997-09-25
EP0586589B1 (en) 1997-08-20
DE69221725T2 (de) 1997-12-18
ES2108122T3 (es) 1997-12-16
AU2011592A (en) 1992-12-30
US5656590A (en) 1997-08-12

Similar Documents

Publication Publication Date Title
IL99905A0 (en) Morphine prodrugs
HUT74452A (en) Preparation for substitution therapy, containing at least one progestogen and at least one extrogen
ATE185548T1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
WO1994027589A3 (en) Antidepressant dosage form
GB9408775D0 (en) Use of certain methanebisphosphonic acid derivatives to prevent prothesis loosening and prothesis migration
HUT66429A (en) Compositions for treating osteoporosis
GR3007385T3 (da)
GR3022321T3 (en) Use of il-4 to treat solid tumors
SG49239A1 (en) Amylin and possibly insulin containing composition for the treatment of aneroxia and related states
GR3029887T3 (en) Method of preparing a radioactive rhenium complex solution.
DE69316013D1 (de) Verwendung von phosphinate zur behandlung der osteoporose
UA42819C2 (uk) Ін`єкційний та інфузійний розчин, що містить енрофлокcацин
IL103383A0 (en) Pharmaceutical compositions containing glutamine and methods for the use thereof
TW261532B (da)
LTIP1534A (en) Medicinal preparations for prophylaxis and treating metabolic disturbance of lipoids and cholesterin
ES8707488A1 (es) Un metodo para preparar maleato de 2-terc-butilamino-3'-cloropropiofenona
TW330933B (en) Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
AU7718796A (en) 4-hydroxycoumarin-3-carboxamides for the treatment of diabetes mellitus
AU6826887A (en) 5-substituted octahydroindolizine analgesics compounds and 7-keto intermediates
IL129267A0 (en) Treatment of urinary incontinence and compositions for use therein
IL98200A0 (en) Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
ATE174694T1 (de) Armband- oder taschenuhr
AU2716592A (en) Treatment of anxiety in benzodiazepine-withdrawn patients
BG94567A (en) Medicaments for the treatment of aids and method for its application
IL117734A0 (en) Beta-carbolines and pharmaceutical compositions containing them